Overview
Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome (also known as Gorlin-Cervenka syndrome or Cervenka syndrome) is an extremely rare genetic condition characterized by the combination of sensorineural hearing loss, genital anomalies, and bony fusion (synostosis) of the metacarpal and metatarsal bones in the hands and feet. The syndrome affects multiple body systems, primarily the auditory system, the skeletal system, and the urogenital system. Key clinical features include congenital sensorineural deafness, which may range from moderate to severe, abnormalities of the genitalia (such as hypospadias or cryptorchidism in males), and radiographic evidence of fusion between the fourth and fifth metacarpal and/or metatarsal bones. Additional skeletal anomalies may also be present. The condition has been described in only a very small number of families in the medical literature, making it one of the rarest syndromic forms of hearing loss. Because of its extreme rarity, the natural history and full phenotypic spectrum of this syndrome remain incompletely characterized. There is currently no specific curative treatment for this condition. Management is supportive and multidisciplinary, involving audiological intervention (such as hearing aids or cochlear implants), surgical correction of genital anomalies when indicated, and orthopedic evaluation for skeletal manifestations. Genetic counseling is recommended for affected families.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome.
Community
No community posts yet. Be the first to share your experience with Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome.
Start the conversation →Latest news about Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome
No recent news articles for Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome
What is Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome?
Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome (also known as Gorlin-Cervenka syndrome or Cervenka syndrome) is an extremely rare genetic condition characterized by the combination of sensorineural hearing loss, genital anomalies, and bony fusion (synostosis) of the metacarpal and metatarsal bones in the hands and feet. The syndrome affects multiple body systems, primarily the auditory system, the skeletal system, and the urogenital system. Key clinical features include congenital sensorineural deafness, which may range from moderate to severe, abnormalities of the ge
How is Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome inherited?
Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome typically begin?
Typical onset of Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome is neonatal. Age of onset can vary across affected individuals.